ID: ALA4102350

Max Phase: Preclinical

Molecular Formula: C10H8ClN3O2

Molecular Weight: 237.65

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1nc(NC(=O)c2cnco2)ccc1Cl

Standard InChI:  InChI=1S/C10H8ClN3O2/c1-6-7(11)2-3-9(13-6)14-10(15)8-4-12-5-16-8/h2-5H,1H3,(H,13,14,15)

Standard InChI Key:  UJPIVPRSEZUCCZ-UHFFFAOYSA-N

Associated Targets(non-human)

MDCK-II 565 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 237.65Molecular Weight (Monoisotopic): 237.0305AlogP: 2.28#Rotatable Bonds: 2
Polar Surface Area: 68.02Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.52CX Basic pKa: 1.65CX LogP: 1.04CX LogD: 1.04
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.87Np Likeness Score: -1.69

References

1. Siddiqui-Jain A, Hoj JP, Hargiss JB, Hoj TH, Payne CJ, Ritchie CA, Herron SR, Quinn C, Schuler JT, Hansen MDH..  (2017)  Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms.,  27  (17): [PMID:28780159] [10.1016/j.bmcl.2017.07.063]

Source